ACNU Feasibility

View full report
OKVyleesi, a prescription subcutaneous injection, involves moderate side effects, dosing complexity, and monitoring needs, with manageable misuse risk and some special population cautions, aligning with FDA ACNU safety and usability considerations.

ACNU Feasibility Scorecard

Chart with 11 data points.
Vyleesi
The chart has 1 X axis displaying categories.
The chart has 1 Y axis displaying ← Lower is Better!. Data ranges from 1 to 6.
End of interactive chart.